SevenOneSeven Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

SevenOneSeven Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-115	Closed	-$13.3K	–	30
2023 Q3	$13.3K	Hold	115	–	–	0.03%	52
2023 Q2	$14.8K	Hold	115	–	–	0.03%	51
2023 Q1	$15K	Hold	115	–	–	0.03%	54
2022 Q4	$15.1K	Hold	115	–	–	0.03%	56
2022 Q3	$13K	Hold	115	–	–	0.03%	51
2022 Q2	$14K	Hold	115	–	–	0.03%	51
2022 Q1	$15K	Hold	115	–	–	0.03%	46
2021 Q4	$18K	Hold	115	–	–	0.04%	48
2021 Q3	$19K	Hold	115	–	–	0.05%	47
2021 Q2	$19K	Hold	115	–	–	0.05%	47
2021 Q1	$17K	Buy	+115	New	+$18.3K	0.06%	55

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SevenOneSeven Capital Management's IBB Position: Q4 2023 in Review

SevenOneSeven Capital Management sold out of iShares Biotechnology ETF (IBB) in Q4 2023, closing a stake of 115 shares — an estimated $13.3K sold.

SevenOneSeven Capital Management first reported a position in IBB in Q1 2021 and held it in 11 quarters. The position peaked at $19K in Q3 2021. 872 funds tracked by Wall St. Rank hold IBB as of Q4 2023.

SevenOneSeven Capital Management reported no remaining iShares Biotechnology ETF position as of Q4 2023 after selling out during the quarter.
SevenOneSeven Capital Management sold 115 iShares Biotechnology ETF shares in Q4 2023, an estimated $13.3K.
SevenOneSeven Capital Management first reported a position in iShares Biotechnology ETF in Q1 2021 and held it in 11 quarters.
SevenOneSeven Capital Management's iShares Biotechnology ETF position peaked at $19K in Q3 2021.
872 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2023.

Based on SevenOneSeven Capital Management's 13F filing for Q4 2023, filed 12 Feb 2024.